Journal of Clinical Endocrinology & Metabolism, Vol 47, 243-248, Copyright © 1978 by Endocrine Society

ARTICLES

Cortisol production and inactivation by the human lung during gestation and infancy

BE Murphy

The enzyme which interconverts the active hormone cortisol (F) and its biologically inactive analog cortisone (E), viz. 11 beta-hydroxysteroid dehydrogenase, is known to be present in many tissues. In this study, its possible role as a regulator of cortisol concentration in the human lung was investigated. Small amounts of minced tissue were incubated for 2 h at 37 C in the presence of tracer F or E. After extraction, the steroids were chromatographed using Sephadex LH-20 column chromatography. From 11-21 weeks of gestation, inactivation of F to E occurred (54.7 +/- 8.0%), while in 11 premature infants there was no conversion in either direction and in 9 infants (4 months to 2 yr of age) there was slight conversion of E to F (7.0 +/- 3.4%). Activity in children was negligible. Lung tissue from 4 anencephalics (35-40 + weeks) retained the ability to inactivate F to E (21.3 +/- 4.3%), though to a lesser extent (P less than 0.01) than fetuses up to 21 weeks. The validity of these in vitro studies was borne out by assays of the endogenous steroids in lung tissue and serum. These results suggest that there is an alteration from rapid inactivation of F to E in early fetal life to slight F production in infancy and that this change is advanced by pituitary or other factors which are decreased in anencephaly. This decreasing inactivation by the lung during late gestation results in higher intracellular F levels which probably act to promote lung maturation in preparation for birth.

This article has been cited by other articles:

				M. R. Garbrecht, T. J. Schmidt, Z. S. Krozowski, and J. M. Snyder 11beta-Hydroxysteroid dehydrogenase type 2 and the regulation of surfactant protein A by dexamethasone metabolites Am J Physiol Endocrinol Metab, April 1, 2006; 290(4): E653 - E660. [Abstract] [Full Text] [PDF]

				J. W. Tomlinson, E. A. Walker, I. J. Bujalska, N. Draper, G. G. Lavery, M. S. Cooper, M. Hewison, and P. M. Stewart 11{beta}-Hydroxysteroid Dehydrogenase Type 1: A Tissue-Specific Regulator of Glucocorticoid Response Endocr. Rev., October 1, 2004; 25(5): 831 - 866. [Abstract] [Full Text] [PDF]

				S. Suzuki, K. Koyama, A. Darnel, H. Ishibashi, S. Kobayashi, H. Kubo, T. Suzuki, H. Sasano, and Z. S. Krozowski Dexamethasone Upregulates 11{beta}-Hydroxysteroid Dehydrogenase Type 2 in BEAS-2B Cells Am. J. Respir. Crit. Care Med., May 1, 2003; 167(9): 1244 - 1249. [Abstract] [Full Text] [PDF]

				B. E. ORSIDA, Z. S. KROZOWSKI, and E. H. WALTERS Clinical Relevance of Airway 11beta -Hydroxysteroid Dehydrogenase Type II Enzyme in Asthma Am. J. Respir. Crit. Care Med., April 1, 2002; 165(7): 1010 - 1014. [Abstract] [Full Text] [PDF]

				M. B. Feinstein and R. P. Schleimer Regulation of the Action of Hydrocortisone in Airway Epithelial Cells by 11beta -Hydroxysteroid Dehydrogenase Am. J. Respir. Cell Mol. Biol., September 1, 1999; 21(3): 403 - 408. [Abstract] [Full Text]